Office of Research Message from the Vice Deans of Research Leadership & Staff Clinical Trials Administration Research Support & Development Biostatistical Resources Grant Support & Review Services NIH K and F Submissions Guide Training Grant Support NIH Resubmission Program NIH Resources NIH Boot Camp Physician Scientist Resources Guidance for Proposal Submissions Grant Incentive Programs and Pilot Awards Researcher Pipeline Policies and Guidelines Environmental Health and Safety Human Research Foreign Affiliations School Center Guidelines Space Allocation Vendor Event Policy Responsible Conduct of Research Rigor and Responsibility COVID-19 Response Funding Opportunities School of Medicine Funding Search Tool Faculty Research Retreat School of Medicine Funding Search Tool Home Research Office of Research School of Medicine Funding Search Tool Below is a curated, searchable and filterable list of funding opportunities announced by NIH in their weekly NIH guide LISTSERV. This list reflects funding opportunities pertinent to many UCI researchers. Using filters may reduce your results, so use judiciously. Opportunities are added weekly. You can sign up for the NIH guide listserv to receive a comprehensive list of funding opportunities every Friday. NIH Guide Listserv Search Funding Discipline - Any -Acute/Chronic PainAgingAlcoholism, Alcohol UseAlzheimer's/DementiaAmyotrophic lateral sclerosis (ALS)Artificial Intelligence/Machine LearningAutoimmune/ImmunologyBehavioral and Social ScienceBiomedical ImagingBiomedical TechnologyBrain DisordersCancerCancer GenomicsCannabinoid/CannabidiodCardiology/VascularCaregiving ResearchChronic ConditionsClimate ChangeClinical TrialsClinical/DiagnosticCoronaviruses/COVIDData Science/Software/DatabasesDiabetesDigestive/KidneyDissemination and Implementation ResearchDown SyndromeEarly career research awardEating DisordersEmergency CareEnvironmental healthEpilepsyEye Disease and Disorders of VisionFood AllergiesGene TherapyGenetic TestingGynecologyHealth Disparities/Social determinantsHealthcare deliveryHearing LossHematologyHIV/AIDSHuman GenomeHuntington's DiseaseInfectious Diseases/MicrobiologyLung/RespiratoryMedical EducationMental Health/IllnessMicrobiomeMusculoskeletal/SkinN/ANeurology/NeurodegenerativenoneNutritionObesityOrthopedicOtolaryngology-Head & Neck SurgeryPathologyPatient Care/SafetyPediatricPhysical ActivityPhysical RehabilitationPneumonia & InfluenzaPost-Traumatic Stress Disorder (PTSD)Precision MedicinePregnancy/Maternal Health/ObstetricsRadiation OncologyRare DiseasesRegenerative MedicineSepsisSickle Cell DiseaseSleepSpinal Cord InjuryStem Cell ResearchStrokeSubstance Abuse/AddictionSuicideSurgeryTelehealthTransplantationTraumatic Brain Injury (TBI)UrologyVaccine RelatedVector-Borne DiseasesViolenceWomenWound Healing and Care Date Range Min Max 2024 Deadline 3: Sep 26, 2024 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) (PAR-24-075) The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this notice of funding opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction. National Institutes of Health (NIH) Federal Early career research award 2024 Deadline 3: Sep 26, 2024 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required) (PAR-24-076) The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction. National Institutes of Health (NIH) Federal Early career research award 2024 Deadline 2: Sep 27, 2024 Translational Neural Devices (R61/R33 - Clinical Trial Optional) (PAR-24-151) The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of low risk therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Clinical/Diagnostic 2024 Deadline 3: Oct 04, 2024 Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) (PAR-23-245) The purpose of this Notice of Funding Opportunity (NOFO) is to advance the development of novel informatics and data science approaches that can help individuals understand and improve their health through actionable insights. National Institutes of Health (NIH) Federal Healthcare delivery 2024 Deadline 3: Oct 05, 2024 Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) (PAR-23-153) This notice of funding opportunity (NOFO) aims to support innovative research relevant to advancing the understanding of the effects of climate change across the cancer control continuum, from cancer etiology and cancer risks through survivorship, and ways to prevent or mitigate negative health effects National Institutes of Health (NIH) Federal Cancer Climate Change Healthcare delivery 2024 Deadline 3: Oct 05, 2024 NIH Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) This Funding Opportunity Announcement (NOFO) invites research grant applications that propose the development and evaluation of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain and the incorporation of pilot or clinical feasibility evaluation from previously collected data in pre-clinical studies. These studies are expected to provide the requisite data needed to advance promising PET ligands for use in clinical research. Projects proposing only preclinical animal studies should consider the companion NOFO (PAR-23-164). National Institutes of Health (NIH) Federal Biomedical Imaging Neurology/Neurodegenerative 2024 Due Date 3: Oct 05, 2024 Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) (PAR-23-168) The overarching goal of this Notice of Funding Opportunity (NOFO) is to support the development and validation of screening assays for the discovery of validated hits that can be used in future drug discovery/development efforts for identifying potential drug candidates for the treatment of mental illness. For purposes of this initiative, a “hit” is defined as a compound that has the desired activity in a compound screen and whose activity is confirmed upon retesting in orthogonal assays. National Institutes of Health (NIH) Federal Brain Disorders Mental Health/Illness Neurology/Neurodegenerative 2024 Deadline 3: Oct 05, 2024 Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) (PAR-23-170) The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations that experience health disparities. National Institutes of Health (NIH) Federal Cancer Caregiving Research Health Disparities/Social determinants 2024 Deadline 3: Oct 05, 2024 Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) (PAR-23-155) This Notice of Funding Opportunity (NOFO) will solicit mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites, and contexts in which expectancy effects can be leveraged to improve cancer outcomes. National Institutes of Health (NIH) Federal Behavioral and Social Science Cancer Healthcare delivery 2024 Deadline 3: Oct 05, 2024 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) (PA-23-189) This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular, and circuit substrates of neural function. For the purposes of this NOFO , the term “complex” can refer to a multifactorial contribution to risk (e.g., polygenic and/or environmental) and/or highly distributed functional features of the brain disorder. National Institutes of Health (NIH) Federal Brain Disorders Neurology/Neurodegenerative Pagination First page « First Previous page ‹‹ Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page ›› Last page Last »
2024 Deadline 3: Sep 26, 2024 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) (PAR-24-075) The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this notice of funding opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction. National Institutes of Health (NIH) Federal Early career research award
2024 Deadline 3: Sep 26, 2024 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required) (PAR-24-076) The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction. National Institutes of Health (NIH) Federal Early career research award
2024 Deadline 2: Sep 27, 2024 Translational Neural Devices (R61/R33 - Clinical Trial Optional) (PAR-24-151) The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of low risk therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Clinical/Diagnostic
2024 Deadline 3: Oct 04, 2024 Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) (PAR-23-245) The purpose of this Notice of Funding Opportunity (NOFO) is to advance the development of novel informatics and data science approaches that can help individuals understand and improve their health through actionable insights. National Institutes of Health (NIH) Federal Healthcare delivery
2024 Deadline 3: Oct 05, 2024 Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) (PAR-23-153) This notice of funding opportunity (NOFO) aims to support innovative research relevant to advancing the understanding of the effects of climate change across the cancer control continuum, from cancer etiology and cancer risks through survivorship, and ways to prevent or mitigate negative health effects National Institutes of Health (NIH) Federal Cancer Climate Change Healthcare delivery
2024 Deadline 3: Oct 05, 2024 NIH Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) This Funding Opportunity Announcement (NOFO) invites research grant applications that propose the development and evaluation of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain and the incorporation of pilot or clinical feasibility evaluation from previously collected data in pre-clinical studies. These studies are expected to provide the requisite data needed to advance promising PET ligands for use in clinical research. Projects proposing only preclinical animal studies should consider the companion NOFO (PAR-23-164). National Institutes of Health (NIH) Federal Biomedical Imaging Neurology/Neurodegenerative
2024 Due Date 3: Oct 05, 2024 Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) (PAR-23-168) The overarching goal of this Notice of Funding Opportunity (NOFO) is to support the development and validation of screening assays for the discovery of validated hits that can be used in future drug discovery/development efforts for identifying potential drug candidates for the treatment of mental illness. For purposes of this initiative, a “hit” is defined as a compound that has the desired activity in a compound screen and whose activity is confirmed upon retesting in orthogonal assays. National Institutes of Health (NIH) Federal Brain Disorders Mental Health/Illness Neurology/Neurodegenerative
2024 Deadline 3: Oct 05, 2024 Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) (PAR-23-170) The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations that experience health disparities. National Institutes of Health (NIH) Federal Cancer Caregiving Research Health Disparities/Social determinants
2024 Deadline 3: Oct 05, 2024 Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) (PAR-23-155) This Notice of Funding Opportunity (NOFO) will solicit mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites, and contexts in which expectancy effects can be leveraged to improve cancer outcomes. National Institutes of Health (NIH) Federal Behavioral and Social Science Cancer Healthcare delivery
2024 Deadline 3: Oct 05, 2024 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) (PA-23-189) This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular, and circuit substrates of neural function. For the purposes of this NOFO , the term “complex” can refer to a multifactorial contribution to risk (e.g., polygenic and/or environmental) and/or highly distributed functional features of the brain disorder. National Institutes of Health (NIH) Federal Brain Disorders Neurology/Neurodegenerative